Complications, Recovery, and Long-Term Outlook
At a Glance
After an SCLS attack, recovery requires monitoring for kidney injury, muscle damage, blood clots, and pulmonary edema. Preventive IVIG, specialist follow-up, rehabilitation, and emotional support can help reduce future risks and support stable health.
Surviving an attack of Systemic Capillary Leak Syndrome (SCLS) is a major milestone, but the journey does not always end when the leak stops. Because an SCLS flare affects almost every system in your body, complications can arise both during the “leak” and while you are recovering. Understanding these risks can help you and your care team navigate the path to long-term health [1][2].
Major Physical Complications
During a flare, the combination of low blood flow, thickened blood, and massive swelling can lead to several serious conditions that require specialized ICU management:
- Acute Kidney Injury (AKI): Your kidneys are highly sensitive to changes in blood pressure. When your blood volume drops during a leak, the kidneys may not receive enough oxygen to function, leading to AKI [1]. In some cases, temporary dialysis (renal replacement therapy) is needed to filter the blood until the kidneys recover [3][4].
- Rhabdomyolysis: This occurs when severe swelling or low blood flow causes muscle tissue to break down. This breakdown releases a protein called myoglobin into the blood, which can further damage the kidneys [5][6].
- Limb Compartment Syndrome: As fluid fills the tight compartments of your muscles, the pressure can cut off circulation. This is a surgical emergency. A procedure called a fasciotomy—where a surgeon makes an incision to relieve the pressure—is often necessary to save the limb and prevent permanent nerve damage [7][8].
- Pulmonary Edema: This is a major risk during the “recovery phase.” As the leaked fluid returns to your bloodstream, it can overwhelm your heart and lungs, making it difficult to breathe [2][9].
- Thrombosis and Ischemia: The heavily concentrated blood (hemoconcentration) combined with immobility during an attack increases the risk of deep vein thrombosis or ischemic complications (lack of blood flow to the organs) [1][10].
Understanding Survival Estimates
The prognosis for SCLS has improved dramatically over the last two decades, a shift strongly associated with the wider use of preventative treatments like IVIG.
- Observational Context: Without optimal preventative treatment, older studies reported 10-year survival rates of around 69% [11].
- Modern Outcomes: With consistent IVIG prophylaxis, small retrospective registry cohorts report 10-year survival rates between 83% and 94% [12][13].
- Individual Prognosis: It is important to understand that these are observational figures from small cohorts and do not precisely predict your individual outcome. Your prognosis depends heavily on factors such as your age, severity of attacks, underlying comorbidities, and access to expert care [12].
The Emotional Impact of Survivorship
Living with a condition that can cause a life-threatening crisis at any moment carries a heavy emotional weight. Many SCLS patients describe a form of “medical trauma” or hyper-vigilance, where every minor cold or bout of fatigue feels like the start of a new attack [14].
It is important to recognize that:
- Fear is a normal response: Validating the anxiety of living with a rare disease is part of your care.
- Support matters: Connecting with patient advocacy groups or mental health professionals who specialize in chronic or rare illnesses can help you manage the psychological toll of the “diagnostic odyssey” and the fear of recurrence.
Long-Term Monitoring
Because SCLS is a chronic condition, you will need a lifelong relationship with a specialist. Your post-flare follow-up timeline should include:
- Kidney Monitoring: Checking your creatinine levels in the weeks following discharge to ensure your kidneys have fully recovered from any acute injury [1].
- Neuromuscular Check-ups: If you experienced compartment syndrome or nerve compression, you may need physical therapy to regain full strength and mobility [8].
- Blood Protein Checks: Adults should have their monoclonal protein (M-spike) levels checked regularly to monitor for any changes that could indicate other blood disorders [11][15].
By combining modern preventative medicine with vigilant monitoring, many SCLS patients can live stable lives between flares [13]. Your care team’s goal is to move you from a state of constant emergency to a state of proactive management.
Common questions in this guide
What complications can happen during or after an SCLS attack?
What does recovery from an SCLS attack involve?
How is regular IVIG related to the outlook for SCLS?
Why can breathing problems occur after an SCLS attack seems to be over?
What emotional support can help after living through an SCLS crisis?
How long will I need monitoring after an SCLS flare?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Systemic capillary leak syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my history, what is my individual risk for 'rebound' pulmonary edema during the recovery phase?
- 2.If I develop acute kidney injury during a flare, what is the plan for initiating temporary dialysis or renal replacement therapy?
- 3.Do you have a specialized physical therapist or neurologist I should see if I have lingering nerve or muscle issues from a past episode?
- 4.How often should we be monitoring my kidney function (creatinine) and muscle enzymes (CK) during the weeks following a flare?
- 5.How can we monitor my risk for blood clots (thrombosis) following an attack?
References
References (15)
- 1
Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease): less is more.
Wu MA, Colombo R, Podda GM, Cicardi M
Internal and emergency medicine 2019; (14(5)):723-730 doi:10.1007/s11739-019-02113-4.
PMID: 31154613 - 2
Recognition and management of idiopathic systemic capillary leak syndrome: an evidence-based review.
Baloch NU, Bikak M, Rehman A, Rahman O
Expert review of cardiovascular therapy 2018; (16(5)):331-340 doi:10.1080/14779072.2018.1456920.
PMID: 29564922 - 3
[Hypotension and Generalized Edema Due to Plasma Leakage: A Case Report].
Gatto S, Di Maria A, Bonesso C, et al.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2024; (41(5)) doi:10.69097/41-05-2024-07.
PMID: 39508706 - 4
Capillary leak syndrome: State of the art in 2021.
Bichon A, Bourenne J, Gainnier M, Carvelli J
La Revue de medecine interne 2021; (42(11)):789-796 doi:10.1016/j.revmed.2021.05.012.
PMID: 34099313 - 5
Clarkson disease in critically and non-critically ill patients: insights from the Italian IRIS-CLS registry.
Colombo R, Montomoli J, Lanzi T, et al.
Internal and emergency medicine 2025; (20(4)):991-1001 doi:10.1007/s11739-025-03890-x.
PMID: 40057670 - 6
Idiopathic systemic capillary leak syndrome and related shock in PICU: an underdiagnosed disease?
Piastra M, Portaccio I, Dondi A, et al.
Journal of anesthesia, analgesia and critical care 2026; (6(1)):22 doi:10.1186/s44158-026-00337-3.
PMID: 41514342 - 7
Systemic capillary leak syndrome requiring fasciotomy for limb compartment syndrome: A case report and literature review.
Tanabe M, Hikone M, Sugiyama K, Hamabe Y
Acute medicine & surgery 2022; (9(1)):e756 doi:10.1002/ams2.756.
PMID: 35602907 - 8
Systemic capillary leak syndrome complicated by lower extremity compartment syndrome: a case report.
Ishihara A, Sagishima K, Ejima T, et al.
JA clinical reports 2025; (11(1)):31 doi:10.1186/s40981-025-00795-8.
PMID: 40488969 - 9
Renal Replacement Therapy in Idiopathic Systemic Capillary Leak Syndrome: A Case Report.
Tokutake M, Nakazawa A, Ota M
Cureus 2024; (16(2)):e53982 doi:10.7759/cureus.53982.
PMID: 38476796 - 10
Non-occlusive Mesenteric Ischaemia and Acute Kidney Injury: A Case Report of Severe Idiopathic Systemic Capillary Leak Syndrome.
Correia CP, Guiomar V, Coelho F, Almeida J
European journal of case reports in internal medicine 2019; (6(7)):001156 doi:10.12890/2019_001156.
PMID: 31410358 - 11
Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.
Pineton de Chambrun M, Gousseff M, Mauhin W, et al.
The American journal of medicine 2017; (130(10)):1219.e19-1219.e27 doi:10.1016/j.amjmed.2017.05.023.
PMID: 28602874 - 12
Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease).
Moyon Q, Pineton de Chambrun M, Gousseff M, et al.
The journal of allergy and clinical immunology. In practice 2022; (10(11)):2889-2895 doi:10.1016/j.jaip.2022.07.006.
PMID: 35870726 - 13
Clinical Presentation, Management, and Prognostic Factors of Idiopathic Systemic Capillary Leak Syndrome: A Systematic Review.
Eo TS, Chun KJ, Hong SJ, et al.
The journal of allergy and clinical immunology. In practice 2018; (6(2)):609-618 doi:10.1016/j.jaip.2017.07.021.
PMID: 28939140 - 14
The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission.
Pineton de Chambrun M, Luyt CE, Beloncle F, et al.
Critical care medicine 2017; (45(7)):1216-1223 doi:10.1097/CCM.0000000000002496.
PMID: 28622216 - 15
Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease).
Xie Z, Chen WS, Yin Y, et al.
Journal of leukocyte biology 2018; (103(4)):749-759 doi:10.1002/JLB.5A0817-324R.
PMID: 29360169
This page is for informational purposes only and does not constitute medical advice about systemic capillary leak syndrome. Your specialist and care team should guide urgent complication management, recovery monitoring, and individualized prognosis.